Bioxell

Italian, clinical stage biopharma developing small molecule and antibody therapeutics for chronic inflammatory and autoimmune diseases

placeSegrate, Lombardy, Italy calendar_todayFounded 2002 language bioxell.com

Innovation

34 patent families (7 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace dormant. Cited 590 times.

YearFilings
20131
20141
20151
20161
20171

Investor mix

11 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital545%
Private equity436%
Other / undisclosed218%
Coming soon